经尿道前列腺电切治疗高危前列腺增生症

目的　探讨适合于高危BPH患者的安全、有效的TURP操作方式。方法　 17例高危BPH患者分两组 ,分别进行圆柱形或漏斗形部分TURP ,分析其对疗效的影响。结果　全部患者均安全渡过围手术期。Ⅱ组 :切除组织 9 4± 3 8g、手术时间平均 2 8 8min、失血量 4 8 6± 2 1 8ml。术后 2个月MFR14 4± 3 4ml/s、IPSS10 1± 2 3分。QOL 1 8± 0 6分。两组的MFR、IPSS具有显著性差异 (P <0 0 1)。结论　漏斗形部分TURP对高危BPH是一种值得推荐的治疗方法。     

经尿道前列腺切开术治疗前列腺增生症疗效观察

目的评价经尿道前列腺切开术(TUIP)治疗年龄较轻或高龄高危的小体积前列腺增生症(BPH)的疗效.方法采用TUIP治疗BPH患者41例.结果手术时间10～30min,平均随访2年,术后国际前列腺症状评分(IPSS)由(25.9±4.2)分降至(10.3±3.1)分(P＜0.05),最大尿流率(MFR)由(6.4±2.4)ml/s上升至(13.2±3.4)ml/s(P＜0.05),剩余尿(RU)由(92.5±45.8)ml降至(24.4±16.8)ml(P＜0.05).逆行射精发生率为7.1%(2/28).结论对于BPH＜35g,TUIP可取得与经尿道前列腺汽化术(TUVP)相似的疗效,且逆行射精、膀胱颈挛缩及阳痿的发生率低,适用于症状明显的年龄偏小或高龄高危的小体积BPH患者.     

前列腺电气化加电切术治疗高危良性前列腺增生症(附273例报告)

目的　探讨经尿道前列腺电气化术 (TUVP)结合经尿道前列腺电切术 (TURP)在高危良性前列腺增生症(BPH)中的应用。方法　使用TUVP结合TURP对 2 73例高危BPH患者进行治疗 ,术后随访观察。结果　术后 15 0例随访 3个月～ 3年 ,IPSS及Qmax评分由术前 2 7.9± 5 .2ml/s和 7.6± 4.7ml/s到术后 7.9± 3 .2ml/s和 18.9± 4.3ml/s (P均 <0 .0 1)。结论　TUVP结合TURP治疗BPH安全、有效 ,并发症少     

经尿道气化电切术治疗高龄高危前列腺增生症

目的　探讨经尿道气化电切术治疗高龄高危前列腺增生症 (BPH)的方法和疗效。方法　采用经尿道前列腺气化电切术治疗高龄高危BPH患者 87例。结果　全部病例均顺利耐受手术。前列腺重 2 2～ 12 8g ,平均 35 .7g ,切除腺体组织重量 9～ 6 1g ,平均 32g。手术时间 2 1～ 87min ,平均 4 9min。国际前列腺症状评分 (IPSS)由术前的 2 6 .8± 4 .2分降至术后 9.3± 3.7分 (t=- 2 7.5 5 ,P <0 .0 1) ;生活质量评分 (QOL)由术前的 5 .9± 0 .8分降至术后 2 .1± 0 .5分 (t=- 2 9.93,P <0 .0 1) ;最大尿流率 (MFR)由术前的 5 .6± 3.7ml s升至术后 18.4± 4 .1ml s(t=14 .95 ,P <0 .0 1) ,平均尿流率 (AFR)由术前的 2 .8± 0 .9ml s升至术后 10 .1± 2 .1ml s(t=17.6 7,P <0 .0 1) ;剩余尿量 (RU)由术前的 183± 6 9.3ml降至术后 35 .2± 16 .3ml(t=- 9.6 4,P <0 .0 1)。随访 3～ 2 4月 ,平均 19月 ,排尿通畅。结论　经尿道前列腺气化电切术是治疗高龄高危BPH患者安全有效的方法     

经尿道电切术治疗良性前列腺增生症206例临床分析

目的　探讨良性前列腺增生症 (BPH )经尿道电切术治疗的效果。方法　采用经尿道前列腺电切术 (TURP)治疗BPH2 0 6例 ,随访 3～ 3 6个月。结果　切除前列腺重量 8.5～ 115 .5 g ,平均 2 8.49g ,手术时间 2 0～ 12 0min ,平均 45 .2 2min。术后留置尿管 5天。最大尿流率 (Qmax)由术前 2～ 12ml/s ,平均 6.66ml/s ,升至术后 3个月 17～ 2 3ml/s ,平均 18.96ml/s ,前列腺症状评分 (IPSS)术前 15～ 3 4分 ,平均 2 6.61分 ,术后 3个月降为 6～ 3 1分 ,平均 9.83分 (P <0 .0 1)。结论　TURP安全、并发症少、疗效好 ,重度BPH不是TURP的禁忌证。     

前列腺增生症并膀胱大结石一期腔内治疗的临床研究

目的 :探讨一期腔内治疗前列腺增生症 (BPH)并膀胱大结石的疗效及安全性。方法 :将 BPH并膀胱大结石患者 5 2例 ,分成腔内组 (30例 )和开放组 (2 2例 ) ,腔内组采用经尿道前列腺电切 (TU RP)结合气压弹道碎石术 ;开放组采用经耻骨上膀胱切开取石 +前列腺摘除术 ,比较两类术式的疗效及安全性。结果 :所有病例均一次治疗成功。两组病例平均手术时间、术后继发出血发生率及术后出院时 IPSS(国际前列腺症状评分 )、QOL (生活质量评分 )、MFR(最大尿流率 )比较 ,差异均无统计学意义 (P >0 .0 5 )。腔内组和开放组的术中出血量、术后膀胱冲洗时间、留置尿管时间分别为 (131.7± 36 .1) ml、(2 .9± 1.6 ) d、(5 .0± 1.2 ) d和 (2 0 9.8± 32 .5 ) h、(4 .8± 2 .3) d、(11.6± 2 .2 ) d,比较差异有统计学意义 (P <0 .0 5 )。结论 :TURP结合气压弹道碎石术一期治疗 BPH并膀胱大结石是一种高效、安全的治疗方法     

经尿道切除术治疗巨大前列腺增生症(附28例报告)

目的　探讨巨大前列腺增生症 (benignprostatichyperplasia,BPH)的治疗方法。方法　回顾性分析 2 8例巨大BPH患者 ,采用经尿道前列腺切除术 (transurethralresectionoftheprostate,TURP)治疗的临床资料。结果　切除前列腺重量 36～90g ,平均切除 5 6 5g ;手术时间 5 0～ 15 0分钟 ,平均 81分钟 ;11例 ( 39%)术中输血 2 0 0～ 40 0ml;前列腺症状评分 (internafionalprostatesymptomscore ,IPSS)由术前平均 2 8 3± 3 4分 ,降至术后 8 3± 3 3分 ;最大尿流率由术前平均 ( 7 6± 2 7)ml/s升至术后平均 ( 2 0 3± 4 8)ml/s;剩余尿由术前 2 0～ 15 0 0ml降至术后 0～ 6 0ml。手术并发症 5例 ( 17 9%) ,其中前列腺电切综合征(transurethralresectionsyndrome ,TURS) 1例 ,冲洗液外渗入腹腔 1例 ,继发出血 3例。复发 1例。结论　TURP治疗巨大BPH安全、并发症少、疗效好。     

经尿道治疗小体积良性前列腺增生效果评价

①目的　评价经尿道前列腺电切加膀胱颈内切开术 (TURP +TUIBN)治疗小体积良性前列腺增生(BPH)的效果。②方法　 1 998年 1 1月～ 2 0 0 0年 1 2月 ,我科采用TURP +TUIBN治疗小体积良性前列腺增生病人 2 2例。③结果　手术时间 35～ 5 0min ,术后国际前列腺症状评分 (IPSS)由 (2 7.3± 5 .1 )分降至 (6 .1± 3.4 )分(t=1 6 .2 2 ,P <0 .0 5 ) ,最大尿流率 (MFR)由 (5 .9± 3.8)mL/s上升到 (2 0 .2± 4 .7)mL/s(t =1 1 .0 9,P <0 .0 5 ) ,残余尿 (RU)由 (1 2 0 .0± 5 4 .2 )mL降至 (2 7.2± 1 5 .8)mL(t′ =7.71 ,P <0 .0 5 )。④结论　TURP +TUIBN是治疗小体积良性前列腺增生引起膀胱颈出口梗阻较为理想的方法     

经尿道气化加电切术治疗前列腺增生症(附150例报告)

目的 探讨良性前列腺增生症(BPH)的有效治疗方法。方法 采用经尿道前列腺气化电切(TUEVAP)加经尿道前列腺电切术(TURP)联合治疗BPH患者150例。结果 手术时间20～90min,平均45min。无电切综合征发生。术后3～5天拔除导尿管,排尿均通畅。96例随访3个月,IPSS由术前21.5±3.5下降至术后9±2.1(P<0.01),OOL由术前5.0±0.85下降至术后1.5±0.15(P<0.01),最大尿流率MFR(ml/s)由术前平均(7.8±4.2)ml/s上升至术后17.0±5.3ml/s(P<0.01),平均尿流率AFR(ml/s)由术前3.8±2.1升至术后9.6±2.2(P<0.01),B超复查残余尿(RU)由术前(100±20.5)ml下降至术后(20.0±13.6)ml(P<0.01)。尿道狭窄3例,性功能减退13例,无尿失禁。结论 TUEVAP加TURP是联合治疗BPH安全有效的方法。     

经尿道汽化术加电切术治疗前列腺增生症228例报告

目的　探讨良性前列腺增生症 (BPH)的有效治疗方法。方法　采用经尿道前列腺汽化 (TUVP)加经尿道前列腺电切术 (TURP)联合治疗BPH患者 2 2 8例。结果　疗效满意 ,术后 3个月随访前列腺症状评分 (IPSS)由术前 2 6 .5±2 .5分降至 7± 0 .4分 (P <0 .0 1 ) ,生活质量评分 (QOL)由术前 4 .5± 0 .2分降至 1 .8± 0 .1 7分 (P <0 .0 1 ) ,剩余尿量由术前 1 1 5± 1 8ml降至 2 5± 2 .3ml(P <0 .0 1 )。且无严重并发症发生。结论　TUVP加TURP是一种治疗BPH安全性高 ,并发症少、疗效确切的新方法。术中冲洗液加温非常重要     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.